Sloane J, Ranchod P, Williams G, Clark SK.
by
Stay Up to Date as We Uncover More About Desmoid Tumors
Your Donation Changes Lives
Every donation, no matter the size, helps us continue our mission.
Walczak BE, Rose PS.
Saleem O, Sayres S, O’Malley M.
Chu KF, Samara MS, Laver N, Wein RO
Bonvalot S, Ternès N, Fiore M, Bitsakou G, Colombo C, Honoré C, Marrari A, Le Cesne A, Perrone F, Dunant A, Gronchi A.
The aim of this study was to investigate the characteristics and outcomes of patients with resectable DTs. A total of 21 patients were included and their clinicopathological characteristics were retrospectively analyzed. The median relapse-free survival (RFS) was 20.5 months for the patients treated by surgery alone and 50 months for those treated with surgery followed by adjuvant RT (P>0.05). Age, gender, SM and adjuvant RT were not identified as predictors of recurrence. No predictive factors appeared to indicate local DT recurrence following surgery.
